Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 6/20 | 0.96 |
| ▸ | CA1 | P00915 | 6/20 | 0.96 |
| ▸ | CA2 | P00918 | 6/20 | 0.96 |
| ▸ | CA7 | P43166 | 6/20 | 0.96 |
| ▸ | CA9 | Q16790 | 6/20 | 0.96 |
| ▸ | CA14 | Q9ULX7 | 6/20 | 0.96 |
| ▸ | ESR1 | P03372 | 3/20 | 0.96 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.96 |
| ▸ | TSHR | P16473 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.69 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.69 |
| ▸ | KDR | P35968 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 3/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | MAOA | P21397 | 1/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylparaben SCHEMBL27833843 | 0.98 | CA12 (0.92) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL28368 | 0.98 | CA12 (1.00) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL5311680 | 0.98 | CA12 (1.00) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL29374744 | 0.96 | CA12 (0.96) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL31655760 | 0.96 | CA12 (0.96) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL23497074 | 0.96 | CA12 (0.96) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL29358972 | 0.96 | CA12 (0.96) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL31347872 | 0.96 | CA12 (0.96) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL476012 | 0.96 | CA12 (0.96) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL29290346 | 0.96 | CA12 (0.96) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1587 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120983376-B | Clofazimine soft capsule and preparation method thereof | SHANXI LIYE PHARMACEUTICAL Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| EP-4743053-A1 | ANTIMICROBIAL SYNERGIES | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| CN-119905535-B | Olivine sodium iron phosphate composite material and preparation method and application thereof | 四川易纳能新能源科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026088186-A1 | FERMENTED AND DEHYDRATED ALOE GEL PRODUCT AND PROCESS FOR THE PREPARATION THEREOF | YOSHAY IDO MOSHE (IL) | 2026-04-30 | — | — | WO | claimed |
| WO-2026090627-A1 | STABLE PITOLISANT LIQUID FORMULATIONS AND METHOD OF ITS USE | PATEL SANDIPKUMAR (US) | 2026-04-30 | — | — | WO | claimed |
| US-20260069570-A1 | STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE | SLAYBACK PHARMA LLC (US) | 2026-03-12 | — | — | US | claimed |
| EP-4554551-B1 | 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS | SYMRISE AG (DE) | 2026-03-11 | — | — | EP | claimed |
| US-20260048055-A1 | Compositions Containing Ibrutinib | JANSSEN PHARMACEUTICA NV (BE) | 2026-02-19 | — | — | US | claimed |
| US-12491178-B2 | Stable pharmaceutical compositions of edaravone | SLAYBACK PHARMA LLC (US) | 2025-12-09 | — | — | US | claimed |
| EP-3843703-B1 | PARACETAMOL LIQUID SUSPENSIONS | HALEON CH SARL (CH) | 2025-11-05 | — | — | EP | claimed |
| US-20100313620-A1 | CALCIUM FORMIATE FERTILISER | LANXESS DEUTSCHLAND GMBH (DE) | 2010-12-16 | — | — | US | claimed |
| WO-2010016034-A2 | POLYMERIC MATERIALS FOR ACTIVE FOOD PACKAGINGS ABLE TO PROTECT AND TO ENHANCE THE QUALITY OF THE CONTAINED FOOD PRODUCTS AND TO REDUCE THEIR PRESERVATION TREATMENTS | Università degli Studi di Salerno (IT) | 2010-02-11 | — | — | WO | claimed |
| US-20080312195-A1 | Preservatives | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2008-12-18 | — | — | US | claimed |
| EP-1845934-B1 | PRESERVATIVES | CLARIANT PRODUKTE DEUTSCHLAND (DE) | 2008-05-14 | — | — | EP | claimed |
| EP-1793925-A2 | IMPREGNATED FILTER ELEMENTS, AND METHODS | DONALDSON COMPANY, INC. (US) | 2007-06-13 | — | — | EP | claimed |
| EP-1452169-B1 | AQUEOUS BASE LIQUID PHARMACEUTICAL COMPOSITIONS IN SUSPENSION FORM FOR THE ORAL ADMINISTRATION OF IBUPROFEN | FARMALIDER SA (ES) | 2007-01-24 | — | — | EP | claimed |
| US-7128923-B2 | Preserved and stable compositions containing peptide copper complexes and method related thereto | PROCYTE CORPORATION (US) | 2006-10-31 | — | — | US | claimed |
| WO-2006026517-A2 | IMPREGNATED FILTER ELEMENTS, AND METHODS | DONALDSON COMPANY, INC. (US) | 2006-03-09 | — | — | WO | claimed |
| US-20060042210-A1 | Acidic impregnated filter element, and methods | DONALDSON COMPANY, INC. | 2006-03-02 | — | — | US | claimed |
| EP-1452169-A1 | AQUEOUS BASE LIQUID PHARMACEUTICAL COMPOSITIONS IN SUSPENSION FORM FOR THE ORAL ADMINISTRATION OF IBUPROFEN | Farmalider, S.A. (ES) | 2004-09-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12491178-B2 | Stable pharmaceutical compositions of edaravone | EDNRA, EDNRB, FASTKD5 | CA12 2889/4885CA1 3192/4885CA2 3254/4885 |
| US-20260069570-A1 | STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE | ADH1C, ADH1A, SLC25A11 | CA12 463/4885CA1 474/4885CA2 270/4885 |
| US-20260048055-A1 | Compositions Containing Ibrutinib | BCL6B, BCL6, BTK | CA12 434/4885CA1 1202/4885CA2 389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.